GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (FRA:4GB) » Definitions » Additional Paid-In Capital

Gossamer Bio (FRA:4GB) Additional Paid-In Capital : €1,178.79 Mil(As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Gossamer Bio Additional Paid-In Capital?


Gossamer Bio's quarterly additional paid-in capital declined from Sep. 2023 (€1,189.15 Mil) to Dec. 2023 (€1,169.30 Mil) but then increased from Dec. 2023 (€1,169.30 Mil) to Mar. 2024 (€1,178.79 Mil).

Gossamer Bio's annual additional paid-in capital increased from Dec. 2021 (€825.66 Mil) to Dec. 2022 (€986.35 Mil) and increased from Dec. 2022 (€986.35 Mil) to Dec. 2023 (€1,169.30 Mil).


Gossamer Bio Additional Paid-In Capital Historical Data

The historical data trend for Gossamer Bio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Additional Paid-In Capital Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 617.75 737.83 825.66 986.35 1,169.30

Gossamer Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 983.84 979.82 1,189.15 1,169.30 1,178.79

Gossamer Bio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Gossamer Bio Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Gossamer Bio's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Gossamer Bio (FRA:4GB) Business Description

Traded in Other Exchanges
Address
3013 Science Park Road, Suite 200, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio (FRA:4GB) Headlines

No Headlines